Primary Human Ovarian Epithelial Cancer Cells Broadly Express HER2 at Immunologically-Detectable Levels-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Primary Human Ovarian Epithelial Cancer Cells Broadly Express HER2 at Immunologically-Detectable Levels

Published:2012-11-26 Issue:11 Volume:7 Page:e49829
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Lanitis Evripidis,Dangaj Denarda,Hagemann Ian S.,Song De-Gang,Best Andrew,Sandaltzopoulos Raphael,Coukos George,Powell Daniel J.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference49 articles.

1. HER2-positive breast cancer: current and future treatment strategies;RH Engel;Drugs,2007

2. Prevalence and significance of HER-2/neu amplification in epithelial ovarian cancer;YF Wong;Gynecol Obstet Invest,1995

3. HER-2/neu is rate-limiting for ovarian cancer growth. Conditional depletion of HER-2/neu by ribozyme targeting;H Juhl;J Biol Chem,1997

4. Antibody to HER-2/neu receptor blocks DNA repair after cisplatin in human breast and ovarian cancer cells;RJ Pietras;Oncogene,1994

5. HER-2-positive breast cancer: hope beyond trastuzumab;R Bartsch;BioDrugs,2007

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Imaging CAR-NK cells targeted to HER2 ovarian cancer with human sodium-iodide symporter-based positron emission tomography;European Journal of Nuclear Medicine and Molecular Imaging;2024-05-09

2. Pb-214/Bi-214-TCMC-Trastuzumab inhibited growth of ovarian cancer in preclinical mouse models;Frontiers in Chemistry;2024-01-25

3. Enhancing Endosomal Escape and Gene Regulation Activity for Spherical Nucleic Acids;Small;2023-11-06

4. Low-level expression of human Epidermal growth Factor Receptor-2 (HER2) in High-Grade Mullerian Tumors: Implications for therapy decision making;Gynecologic Oncology Reports;2023-10

5. HER2 status as a potential predictive biomarker for ovarian clear cell carcinoma;Virchows Archiv;2023-09-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3